Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Lopinavir"" wg kryterium: Temat


Tytuł:
A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study.
Autorzy:
Reekie J; Research Department of Infection & Population Health, University College London Medical School, Royal Free Campus, London, UK. />Reiss P
Ledergerber B
Sedlacek D
Parczewski M
Gatell J
Katlama C
Fätkenheuer G
Lundgren JD
Mocroft A
Pokaż więcej
Corporate Authors:
EuroSIDA study group
Źródło:
HIV medicine [HIV Med] 2011 May; Vol. 12 (5), pp. 259-68. Date of Electronic Publication: 2010 Aug 31.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Benzoxazines/*therapeutic use
HIV Infections/*drug therapy
HIV Protease Inhibitors/*therapeutic use
Nevirapine/*therapeutic use
Pyrimidinones/*therapeutic use
Reverse Transcriptase Inhibitors/*therapeutic use
Alkynes ; Argentina/epidemiology ; Benzoxazines/adverse effects ; Cyclopropanes ; Drug Administration Schedule ; Drug Resistance ; Drug Therapy, Combination ; Europe/epidemiology ; Female ; HIV Infections/epidemiology ; HIV Infections/virology ; HIV-1 ; Humans ; Israel/epidemiology ; Lopinavir ; Male ; Nevirapine/adverse effects ; Prospective Studies ; Pyrimidinones/adverse effects ; Treatment Outcome ; Viral Load
Czasopismo naukowe
Tytuł:
Cost-effectiveness of atazanavir/ritonavir compared with lopinavir/ritonavir in treatment-naïve human immunodeficiency virus-1 patients in Sweden.
Autorzy:
Thuresson PO; Pharmerit BV, Rotterdam, Netherlands. />Heeg B
Lescrauwaet B
Sennfält K
Alaeus A
Neubauer A
Pokaż więcej
Źródło:
Scandinavian journal of infectious diseases [Scand J Infect Dis] 2011 Apr; Vol. 43 (4), pp. 304-12. Date of Electronic Publication: 2011 Jan 13.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-HIV Agents/*administration & dosage
Antiretroviral Therapy, Highly Active/*methods
HIV Infections/*drug therapy
HIV-1/*isolation & purification
Oligopeptides/*administration & dosage
Pyridines/*administration & dosage
Pyrimidinones/*administration & dosage
Ritonavir/*administration & dosage
Adult ; Anti-HIV Agents/economics ; Antiretroviral Therapy, Highly Active/economics ; Atazanavir Sulfate ; Clinical Trials as Topic ; Cost-Benefit Analysis ; HIV Infections/virology ; Humans ; Lopinavir ; Models, Statistical ; Oligopeptides/economics ; Pyridines/economics ; Pyrimidinones/economics ; Quality-Adjusted Life Years ; Ritonavir/economics ; Sweden
Czasopismo naukowe
Tytuł:
High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia.
Autorzy:
Ferradini L; Family Health International, Phnom Penh, Cambodia.
Ouk V
Segeral O
Nouhin J
Dulioust A
Hak C
Fournier I
Lerolle N
Ngin S
Mean CV
Delfraissy JF
Nerrienet E
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2011 Mar 26; Vol. 14, pp. 14. Date of Electronic Publication: 2011 Mar 26.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-HIV Agents/*therapeutic use
HIV Infections/*drug therapy
Pyrimidinones/*therapeutic use
Adult ; Antiretroviral Therapy, Highly Active ; CD4 Lymphocyte Count ; CD4-Positive T-Lymphocytes/immunology ; Cambodia ; Cohort Studies ; Female ; Follow-Up Studies ; HIV Infections/immunology ; HIV Infections/virology ; HIV-1/classification ; HIV-1/isolation & purification ; HIV-1/metabolism ; Humans ; Lopinavir ; Male ; Middle Aged ; Treatment Outcome ; Viral Load/drug effects
Czasopismo naukowe
Tytuł:
The HIV protease inhibitor lopinavir/ritonavir (Kaletra) alters the growth, differentiation and proliferation of primary gingival epithelium.
Autorzy:
Israr M; Department of Microbiology and Immunology, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
Mitchell D
Alam S
Dinello D
Kishel JJ
Meyers C
Pokaż więcej
Źródło:
HIV medicine [HIV Med] 2011 Mar; Vol. 12 (3), pp. 145-56. Date of Electronic Publication: 2010 Aug 15.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Gingiva/*drug effects
HIV Protease Inhibitors/*pharmacology
Keratinocytes/*drug effects
Pyrimidinones/*pharmacology
Ritonavir/*pharmacology
Cell Differentiation/drug effects ; Cell Proliferation/drug effects ; Cells, Cultured ; Dose-Response Relationship, Drug ; Drug Combinations ; Epithelial Cells/drug effects ; Epithelium/drug effects ; Gingiva/cytology ; Humans ; Lopinavir ; Microscopy, Electron, Transmission
Czasopismo naukowe
Tytuł:
Patent watch: Indian patent office rejects HIV drug formulation patent.
Autorzy:
Harrison C
Pokaż więcej
Źródło:
Nature reviews. Drug discovery [Nat Rev Drug Discov] 2011 Feb; Vol. 10 (2), pp. 88.
Typ publikacji:
Wiadomości
MeSH Terms:
Anti-HIV Agents/*therapeutic use
HIV Infections/*drug therapy
Patents as Topic/*legislation & jurisprudence
Pyrimidinones/*therapeutic use
Anti-HIV Agents/chemistry ; Chemistry, Pharmaceutical ; HIV Infections/epidemiology ; Humans ; India ; Lopinavir ; Pyrimidinones/chemistry
Periodyk
Tytuł:
Ultrafast and high-throughput mass spectrometric assay for therapeutic drug monitoring of antiretroviral drugs in pediatric HIV-1 infection applying dried blood spots.
Autorzy:
Meesters RJ; Department of Neurology, Laboratory of Neuro-Oncology and Clinical and Cancer Proteomics, University Medical Center Rotterdam (Erasmus MC), Dr. Molewaterplein 50, Room Ee-1981, 3015 GE Rotterdam, The Netherlands. />van Kampen JJ
Reedijk ML
Scheuer RD
Dekker LJ
Burger DM
Hartwig NG
Osterhaus AD
Luider TM
Gruters RA
Pokaż więcej
Źródło:
Analytical and bioanalytical chemistry [Anal Bioanal Chem] 2010 Sep; Vol. 398 (1), pp. 319-28. Date of Electronic Publication: 2010 Jul 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization*
Drug Monitoring/*methods
HIV Infections/*blood
HIV Infections/*drug therapy
HIV Protease Inhibitors/*blood
Pyrimidinones/*blood
Ritonavir/*blood
Blood Specimen Collection ; Case-Control Studies ; Child ; Chromatography, High Pressure Liquid ; HIV-1/isolation & purification ; Humans ; Lopinavir
Czasopismo naukowe
Tytuł:
Long-term (96-week) follow-up of antiretroviral-naïve HIV-infected patients treated with first-line lopinavir/ritonavir monotherapy in the MONARK trial.
Autorzy:
Ghosn J; Department of Internal Medicine and Infectious Diseases, AP-HP, Bicêtre University Hospital, Le Kremlin-Bicêtre Cedex, France. />Flandre P
Cohen-Codar I
Girard PM
Chaix ML
Raffi F
Dellamonica P
Ngovan P
Norton M
Delfraissy JF
Pokaż więcej
Corporate Authors:
MONARK Study Group
Źródło:
HIV medicine [HIV Med] 2010 Feb; Vol. 11 (2), pp. 137-42. Date of Electronic Publication: 2009 Aug 13.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV-1*/drug effects
HIV-1*/genetics
HIV Infections/*drug therapy
HIV Protease Inhibitors/*therapeutic use
Pyrimidinones/*therapeutic use
Ritonavir/*therapeutic use
Antiretroviral Therapy, Highly Active/methods ; Drug Administration Schedule ; Drug Resistance, Viral/genetics ; Drug Therapy, Combination ; Follow-Up Studies ; HIV Infections/virology ; Humans ; Intention to Treat Analysis ; Lamivudine/therapeutic use ; Lopinavir ; Male ; Medication Adherence ; RNA, Viral/blood ; RNA, Viral/genetics ; Reverse Transcriptase Inhibitors/therapeutic use ; Treatment Outcome ; Zidovudine/therapeutic use
Czasopismo naukowe
Tytuł:
Bilateral pedal edema in an HIV patient: Lopinavir/Ritonavir-containing treatment regimen as a potential cause?
Autorzy:
Shihab HM; Infectious Diseases Institute, Makerere University, Kampala, Uganda. />Lutwama F
Piloya T
Castelnuovo B
Kambugu AD
Colebunders R
Pokaż więcej
Źródło:
Journal of infection in developing countries [J Infect Dev Ctries] 2009 Jun 01; Vol. 3 (5), pp. 405-7. Date of Electronic Publication: 2009 Jun 01.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Anti-HIV Agents/*adverse effects
Edema/*pathology
HIV Infections/*complications
HIV Infections/*drug therapy
Leg/*pathology
Pyrimidinones/*adverse effects
Ritonavir/*adverse effects
Humans ; Lopinavir ; Male ; Middle Aged ; Uganda
Czasopismo naukowe
Tytuł:
Drug-resistant molecular mechanism of CRF01_AE HIV-1 protease due to V82F mutation.
Autorzy:
Liu X; Department of Bioscience and Biotechnology, School of Environmental and Biological Science and Technology, Dalian University of Technology, Dalian 116024, People's Republic of China. />Xiu Z
Hao C
Pokaż więcej
Źródło:
Journal of computer-aided molecular design [J Comput Aided Mol Des] 2009 May; Vol. 23 (5), pp. 261-72. Date of Electronic Publication: 2009 Feb 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Protease/*genetics
HIV Protease/*metabolism
HIV Protease Inhibitors/*pharmacology
HIV-1/*drug effects
Nelfinavir/*pharmacology
Pyrimidinones/*pharmacology
Amino Acid Sequence ; Amino Acid Substitution ; Catalytic Domain ; Computer Simulation ; Drug Design ; Drug Resistance, Viral ; HIV Protease Inhibitors/metabolism ; HIV-1/genetics ; Humans ; Lopinavir ; Models, Molecular ; Molecular Sequence Data ; Mutation ; Nelfinavir/metabolism ; Protein Binding ; Protein Conformation ; Pyrimidinones/metabolism ; Thermodynamics
Czasopismo naukowe
Tytuł:
Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV-infected, therapy-naïve patients: results of the EPIC study (CCR100136).
Autorzy:
Yeni P; University Hospital Bichat, Paris, France.
Lamarca A
Berger D
Cimoch P
Lazzarin A
Salvato P
Smaill FM
Teofilo E
Madison SJ
Nichols WG
Adkison KK
Bonny T
Millard J
McCarty D
Pokaż więcej
Corporate Authors:
EPIC (CCR100136) study team
Źródło:
HIV medicine [HIV Med] 2009 Feb; Vol. 10 (2), pp. 116-24.
Typ publikacji:
Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV-1*/immunology
Benzoates/*toxicity
HIV Infections/*drug therapy
HIV Protease Inhibitors/*therapeutic use
Piperazines/*toxicity
Pyrimidinones/*therapeutic use
Ritonavir/*therapeutic use
Spiro Compounds/*toxicity
Adult ; Aged ; Benzoates/pharmacokinetics ; Diketopiperazines ; Drug Administration Schedule ; Drug Therapy, Combination ; Female ; HIV Infections/immunology ; HIV Infections/virology ; HIV Protease Inhibitors/pharmacokinetics ; Humans ; Lopinavir ; Male ; Middle Aged ; Piperazines/pharmacokinetics ; Pyrimidinones/pharmacokinetics ; RNA, Viral/immunology ; Receptors, CCR5/therapeutic use ; Ritonavir/pharmacokinetics ; Spiro Compounds/pharmacokinetics ; Young Adult
Czasopismo naukowe
Tytuł:
Cultured CD4T cells and primary human lymphocytes express hOATPs: intracellular accumulation of saquinavir and lopinavir.
Autorzy:
Janneh O; School of Biomedical Sciences, University of Ulster, Coleraine, County Londonderry, UK. />Hartkoorn RC
Jones E
Owen A
Ward SA
Davey R
Back DJ
Khoo SH
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2008 Nov; Vol. 155 (6), pp. 875-83. Date of Electronic Publication: 2008 Aug 18.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
CD4-Positive T-Lymphocytes/*metabolism
Lymphocytes/*metabolism
Multidrug Resistance-Associated Proteins/*metabolism
Pyrimidinones/*metabolism
Saquinavir/*metabolism
Cells, Cultured ; HIV Protease Inhibitors/metabolism ; Humans ; Lopinavir
Czasopismo naukowe
Tytuł:
Lopinavir/ritonavir monotherapy as maintenance treatment in HIV-infected individuals with virological suppression: results from a pilot study in Brazil.
Autorzy:
Sprinz E; Hospital de Clinicas-Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. />Bay MB
Lazzaretti RK
Jeffman MW
Mattevi VS
Pokaż więcej
Źródło:
HIV medicine [HIV Med] 2008 May; Vol. 9 (5), pp. 270-6. Date of Electronic Publication: 2008 Mar 10.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections/*drug therapy
Pyrimidinones/*administration & dosage
Ritonavir/*administration & dosage
Adult ; Aged ; Antiretroviral Therapy, Highly Active/methods ; Brazil ; CD4 Lymphocyte Count/methods ; Cytochrome P-450 CYP3A ; Drug Administration Schedule ; Female ; HIV Infections/virology ; HIV-1/genetics ; Humans ; Lopinavir ; Male ; Middle Aged ; Pilot Projects ; Polymorphism, Genetic/drug effects ; RNA, Viral ; Viral Load ; Viremia/drug therapy
Czasopismo naukowe
Tytuł:
Stavudine-induced pancreatitis followed by lopinavir-ritonavir-induced pancreatitis.
Autorzy:
Anand H; Department of Clinical Pharmacy, JSS College of Pharmacy, SS Nagara, Mysore, India.
Parthasarathi G
Ramesh M
Pokaż więcej
Źródło:
Journal of postgraduate medicine [J Postgrad Med] 2008 Apr-Jun; Vol. 54 (2), pp. 153-5.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Anti-HIV Agents/*adverse effects
HIV Protease Inhibitors/*adverse effects
Pancreatitis/*chemically induced
Pyrimidinones/*adverse effects
Ritonavir/*adverse effects
Stavudine/*adverse effects
Anti-HIV Agents/administration & dosage ; HIV Infections/blood ; HIV Infections/drug therapy ; HIV Protease Inhibitors/administration & dosage ; HIV-1 ; Humans ; Lopinavir ; Male ; Middle Aged ; Pyrimidinones/administration & dosage ; Ritonavir/administration & dosage ; Stavudine/administration & dosage
Czasopismo naukowe
Tytuł:
Factors associated with altered pharmacokinetics in substance users and non-substance users receiving lopinavir and atazanavir.
Autorzy:
Higgins N; Pharmacotherapy Research Center, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Amherst, New York 14260, USA.
Zingman BS
Slish J
Reichman RC
Fischl MA
Gripshover B
Tooley K
Boston N
Forrest A
Brazeau D
Catanzaro LM
DiFrancesco R
Lliguicota F
Ma Q
Morse GD
Pokaż więcej
Źródło:
The American journal on addictions [Am J Addict] 2007 Nov-Dec; Vol. 16 (6), pp. 488-94.
Typ publikacji:
Comparative Study; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-HIV Agents/*pharmacokinetics
HIV Infections/*drug therapy
HIV Infections/*metabolism
Oligopeptides/*pharmacokinetics
Pyridines/*pharmacokinetics
Pyrimidinones/*pharmacokinetics
Substance-Related Disorders/*metabolism
Adult ; Anti-HIV Agents/blood ; Anti-HIV Agents/therapeutic use ; Antiretroviral Therapy, Highly Active ; Atazanavir Sulfate ; CD4 Lymphocyte Count ; Comorbidity ; Drug Monitoring ; Female ; HIV Infections/epidemiology ; HIV-1 ; Humans ; Lopinavir ; Male ; Methadone/therapeutic use ; Middle Aged ; Patient Compliance ; Pyrimidinones/blood ; Pyrimidinones/therapeutic use ; Smoking/epidemiology ; Substance-Related Disorders/blood ; Substance-Related Disorders/epidemiology
Czasopismo naukowe
Tytuł:
Pharmacokinetics of two randomized trials evaluating the safety and efficacy of indinavir, saquinavir and lopinavir in combination with low-dose ritonavir: the MaxCmin1 and 2 trials.
Autorzy:
Justesen US; Department of Infectious Diseases, Odense University Hospital, Odense C, Denmark. />Fox Z
Pedersen C
Cahn P
Gerstoft J
Clumeck N
Losso M
Peters B
Obel N
Castagna A
Dragsted UB
Lundgren JD
Pokaż więcej
Corporate Authors:
MaxCmin1 and 2 trial groups
Źródło:
Basic & clinical pharmacology & toxicology [Basic Clin Pharmacol Toxicol] 2007 Nov; Vol. 101 (5), pp. 339-44.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Protease Inhibitors/*pharmacokinetics
Indinavir/*pharmacokinetics
Pyrimidinones/*pharmacokinetics
Ritonavir/*therapeutic use
Saquinavir/*pharmacokinetics
Adult ; Double-Blind Method ; Drug Combinations ; Female ; HIV Infections/drug therapy ; HIV Protease Inhibitors/adverse effects ; HIV Protease Inhibitors/therapeutic use ; HIV-1 ; Humans ; Indinavir/adverse effects ; Indinavir/therapeutic use ; Lopinavir ; Male ; Middle Aged ; Pyrimidinones/adverse effects ; Pyrimidinones/therapeutic use ; Saquinavir/adverse effects ; Saquinavir/therapeutic use ; Treatment Failure
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies